|Mr. Daniel S. Goldberger||CEO & Director||187.5k||N/A||1959|
|Mr. Joseph P. Errico||Co-Founder, Principal Investor & Director||776.28k||N/A||1969|
|Mr. Brian M. Posner||CFO & Corp. Sec.||380.54k||N/A||1962|
|Dr. Peter S. Staats||Chief Medical Officer||238.41k||N/A||1964|
|Mr. Michael Romaniw||Exec. VP of Systems & Operations||N/A||N/A||1957|
|Mr. Eric J. Liebler||Sr. VP of Neurology||N/A||N/A||1964|
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.
electroCore, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 8; Compensation: 7.